INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)

• 收藏
• 分享

专利权人:

Inc.;FORMA Therapeutics

发明人:

Patrick F. Kelly,Susan Ashwell

申请号：

US16893147

公开号：

US20200297717A1

申请日:

2020.06.04

申请国别(地区):

US

年份:

2020

代理人:

摘要：

Patients diagnosed with a cancer harboring an IDH-1 mutation can be treated by the administration of a therapeutically effective amount of a pharmaceutical composition comprising Compound 1, a selective inhibitor of 2-HG production from mIDH-1 enzymes including the R132 mutations R132C, R132H, R132L, R132G, and R132S.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/